SRI KRISHNA PHARMACEUTICALS LTD

Overview

SRI KRISHNA PHARMACEUTICALS LTD is an active pharmaceutical ingredient (API) supplier with 11 active FDA Type II Drug Master Files, covering ACETAMINOPHEN USP; BUTORPHANOL TARTRATE USP; DIMETHYL FUMARATE USP; DOMPERIDONE PH EUR; ENALAPRIL MALEATE USP PROCESS-II; FOLIC ACID USP.

API / Drug Master Files

SRI KRISHNA PHARMACEUTICALS LTD holds 11 active (14 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• ENALAPRIL MALEATE USP PROCESS-IIActive2024-07-16
• DIMETHYL FUMARATE USPActive2024-05-29
• GLYBURIDE USPActive2013-04-19
• GLIPIZIDE USPActive2012-05-07
• BUTORPHANOL TARTRATE USPActive2012-01-17
• DOMPERIDONE PH EURActive2010-12-13
• FUROSEMIDE USPActive2009-12-22
• MECLIZINE HYDROCHLORIDE USPActive2009-12-15
• SODIUM PHENYLBUTYRATE USPActive2006-06-30
• FOLIC ACID USPActive2004-08-16
• ACETAMINOPHEN USPActive2002-02-06
• SODIUM PHENYLBUTYRATE GRANULES 100% (KRISOSPB-100)Inactive2010-10-25
• ACETAMINOPHEN GRANULES DC 90%Inactive2004-08-16
• ACETAMINOPHEN GRANULES DC 90% (KRISOPAP 90F)Inactive2004-05-27

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to SRI KRISHNA PHARMACEUTICALS LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.